Tyrosine Kinase-2, Angiopoietin-2, and Thrombomodulin Axes in the Late-Onset Fetal Growth Restriction: A Prospective Cohort Study

Tyrosine Kinase-2, Angiopoietin-2, and Thrombomodulin Axes in the Late-Onset Fetal Growth Restriction: A Prospective Cohort Study

OBJECTIVE: Investigating the interaction among three interconnected proteins, namely receptor Tyrosine Kinase-2 (Tie-2), the vascular remodeling cytokine Angiopoietin-2 (Ang-2), and the coagulation inhibitor Thrombomodulin (TM), may offer fresh insights into the multifactorial origins of late-onset...

Full description

Saved in:

Bibliographic Details
Main Authors:	Esra Altan Erbilen, Fusun Gulizar Varol
Format:	Article
Language:	English
Published:	Medical Network 2024-12-01
Series:	Gynecology Obstetrics & Reproductive Medicine
Subjects:	Angiopoietin-2 Late-onset fetal growth restriction Thrombomodulin Tyrosine kinase-2
Online Access:	https://gorm.com.tr/index.php/GORM/article/view/1500
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Angiopoietin-2 and D-dimer add prognostic information to clinical risk in pulmonary arterial hypertension
by: Heather L. Clark, et al.
Published: (2025-02-01)

miR-1233-3p Inhibits Angiopoietin-1-Induced Endothelial Cell Survival, Migration, and Differentiation
by: Veronica Sanchez, et al.
Published: (2025-01-01)

Over-Expression of MicroRNA-210 and MicroRNA-185-5p in Normotensive Late-Fetal Growth Restriction: Preliminary Cohort Study
by: Esra Altan Erbilen, et al.
Published: (2024-08-01)

Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves’ orbitopathy
by: Yeonjung Yoon, et al.
Published: (2024-09-01)

Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target
by: Yan Li, et al.
Published: (2025-01-01)

Clinical management of bleeding manifestations in a family with the thrombomodulin C1611>A (p.Cys537Stop) mutation
by: Serge Pierre-Louis, et al.
Published: (2025-01-01)

Correlation between salivary ANG-2 level and inflammation activity of oral lichen planus
by: XIANG Yuanyi, LUO Jingjing, LI Haiyang, WU Zhongting, ZHOU Hongmei
Published: (2025-01-01)

The tyrosine kinase inhibitor lenvatinib is oxidized by rat cytochromes P450 and affects their expression in rat liver
by: Indra Radek, et al.
Published: (2024-09-01)

USP8‐Dependent Family Tyrosine Kinase Promotes the Malignant Progression of Esophageal Squamous Cell Carcinoma by Upregulating Protein Tyrosine Kinase 2 Expression
by: Yuechang Wu, et al.
Published: (2025-01-01)

Anti-microbial cetylpyridinium chloride suppresses mast cell function by targeting tyrosine phosphorylation of Syk kinase
by: Bright Obeng, et al.
Published: (2024-12-01)

Cerebrovascular stenosis related to tyrosine kinase inhibitor for chronic myeloid leukemia: two illustrative cases
by: Nozomi Sasaki, et al.
Published: (2025-01-01)

Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in South Africa
by: Rochelle Woudberg, et al.
Published: (2025-01-01)

Evaluation of the Screening Performance of Ultrasonographic Abdominal Circumference and Estimated Fetal Weight in Predicting Small for Gestational Age Newborns
by: Yusuf Dal, et al.
Published: (2024-08-01)

Using In Silico Methods to Identify Protein Tyrosine Kinase A (PtkA) Homolog in Non-Tuberculous Mycobacteria (NTM)
by: Swati Jaiswal, et al.
Published: (2024-11-01)

Endothelin receptor antagonists (ERAs) can potentially be used as therapeutic drugs to reduce hypertension caused by small molecule tyrosine kinase inhibitors (TKIs)
by: Qingjian He, et al.
Published: (2025-01-01)

Insights into the roles of exogenous phenylalanine and tyrosine in improving rapamycin production of Streptomyces rapamycinicus with transcriptome analysis
by: Dongmei Xu, et al.
Published: (2024-12-01)

Tyrosine hydroxylase of the brain and it’s regulation by glucocorticoids
by: E. V. Sukhareva, et al.
Published: (2016-05-01)

Study of vascular endothelial dysfunction in children with beta-thalassemia major before and after quercetin therapy
by: Fatma Al Zahraa Sherai, et al.
Published: (2025-02-01)

Comparative safety profile of tyrosine kinase inhibitors in NSCLC: a network meta-analysis of hypertension and thrombotic risks
by: Mingming Tan, et al.
Published: (2025-01-01)

Rechallenge therapy versus tyrosine kinase inhibitor (TKI) for advanced metastatic colorectal cancer: a retrospective study
by: Chenming Liu, et al.
Published: (2025-02-01)

Induction of tyrosine aminotransferase in mice is inhibited by activated metabolites of ortho- aminoazotoluene
by: V. I. Kaledin, et al.
Published: (2015-07-01)

Effects of Food on the Pharmacokinetics and Safety of HA121-28 Tablet, a Novel Multi-Targeting Tyrosine Kinase Inhibitor, in Healthy Chinese Subjects: A Phase I Clinical Trial
by: Liu Y, et al.
Published: (2025-01-01)

Dynamics of endothelial function in patients with arterial hypertension with different cardiovascular risk against the background of antihypertensive therapy
by: N.O. Pertseva, et al.
Published: (2024-10-01)

Screening of a Soil Tyrosianse Producing Bacterial Strain HM24 and Comparison of its Tyrosinase Activity in Different Mediums Containing Natural Sources of L-tyrosine
by: Seyed Muhammad Hamid Malekpour, et al.
Published: (2024-09-01)

The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute lymphoblastic leukemia
by: Xiaoxia Wu, et al.
Published: (2024-09-01)

Effect of Microbial Community Succession on Tyrosine Metabolism during Soybean Paste Fermentation
by: JIN Manqin, LUO Dan, WANG Gangtu, LI Yixin, PEI Wei, XUE Wentong
Published: (2025-02-01)

Impact of First- and Second-Generation Tyrosine Kinase Inhibitors on the Development of Graft-Versus-Host Disease in Individuals with Chronic Myeloid Leukemia: A Retrospective Analysis on Behalf of the Polish Adult Leukemia Group
by: Ugo Giordano, et al.
Published: (2025-01-01)

Analysis of the aqueous humor before and after the administration of faricimab in patients with nAMD
by: Ryo Nonogaki, et al.
Published: (2024-12-01)

Valerenic acid ameliorates amphetamine-related neurotoxicity by improving hypothalamus tyrosine hydroxylase and histamine-N-methyl transferase enzymes
by: Khaled M.M. Koriem, et al.
Published: (2025-06-01)

Additive Effect of Fetal Magnetic Resonance Imaging to Prenatal Ultrasonography in Fetal Congenital Anomalies
by: Emine Kirtis, et al.
Published: (2024-04-01)

Congenital Chylothorax: Case Report
by: Egemen Tolunay, et al.
Published: (2013-08-01)

Fetal and neonatal cardiac tumor diagnosed as Tuberous Sclerosis associated rhabdomyomas resulting from novel pathogenic missense variant detected in TSC2 gene: A case report
by: Aya Kawasaki, MD, et al.
Published: (2025-03-01)

Blocking ANGPTL3 and CD47 impact on atherosclerosis-correspondence
by: Han-Yong Hou, et al.
Published: (2025-02-01)

Intrauterine Fetal Surgery Current Approaches
by: Ayla Eser, et al.
Published: (2015-04-01)

Ultrasound diagnosis and monitoring of fetal tachyarrhythmias
by: Yu.А. Ivaniv, et al.
Published: (2017-12-01)

Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System
by: Alessandra Puddu, et al.
Published: (2019-01-01)

Impact of type 2 diabetes variants identified through genome-wide association studies in early-onset type 2 diabetes from South Indian population
by: Samuel Liju, et al.
Published: (2020-09-01)

Taltirelin induces TH expression by regulating TRHR and RARα in medium spiny neurons
by: Kedong Zhu, et al.
Published: (2024-12-01)

Protein palmitoylation is involved in regulating mouse sperm motility via the signals of calcium, protein tyrosine phosphorylation and reactive oxygen species
by: Yuping Xiong, et al.
Published: (2025-01-01)

Thrombosed Fetal Dural Sinus Malformation: A Case Report
by: Tayseer Al Muteri, et al.
Published: (2024-12-01)